STERO’s IP:
STERO has filed a patent on May 2016, the patent was granted on August 2018.
The patent named CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES was approved in a little over 2 years!
Patent coverage:
The patent covers the use of CBD for enhancing the therapeutic effect of a steroid, reducing the dose of steroid treatment and for reducing side effects associated with steroids.
the patent has extremely wide coverage of:
- Over 130 Auto immune and Inflammatory diseases by name
- CBD from any source (synthetic or botanic)
- CBD in any combination
- CBD in any dosage
- any delivery system
More importantly, patients with immune diseases that cannot otherwise benefit from CBD treatments (drug not developed for the specific indication as to no patent protection) – can benefit from our treatment and reduce the dose of steroids used to treat their disease.